Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
17492
Beskrivning
NCT00428090 / GSK-AVA105640 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
Nyckelord
Versioner (2)
- 2016-09-18 2016-09-18 -
- 2016-09-25 2016-09-25 -
Uppladdad den
18 september 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC-ND 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GSK Concomitant Medication NCT00428090
GSK Concomitant Medication NCT00428090
- StudyEvent: ODM
Similar models
GSK Concomitant Medication NCT00428090
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Patient Study ID
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Concomitant Medications
Item
Where any concomitant medications taken by the subject during the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name (Trade Name preferred) (e.g. Aspirin) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C0013227 (UMLS CUI [1])
Total Daily Dose
Item
Total Daily Dose (e.g. 400) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C2348070 (UMLS CUI [1])
Units
Item
Units (e.g. mg) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C1519795 (UMLS CUI [1])
Route
Item
Route (e.g. PO) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C0013153 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication (e.g. Headache) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Start date
Item
Start Date (Day Month Year) (e.g. 31 MAY 02) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
date
C0013227 (UMLS CUI [1])
Stop Date
Item
Stop Date (Day Month Year) (e.g. 31 MAY 02) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
date
C0806020 (UMLS CUI [1])
Ongoing Medication
Item
Ongoing Medication (Yes - No) If "YES", record each medication on a seperate line using Trade Names where possible. If the medication is related to an Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
boolean
C2826666 (UMLS CUI [1])
Inga kommentarer